nanotechnology | Science and Enterprise

A company designing gene-edited T-cells as cancer therapies stopped its clinical trial of a treatment for multiple… https://t.co/0PktfkzyNH
about 2 hours ago
New post on Science and Enterprise: FDA Halts Off-the-Shelf Engineered T-Cell Trial https://t.co/Fbz7IKCgky #Science #Business
about 2 hours ago
If you dig deep into the Science & Enterprise archives, you'll find this site began posting on 6 July 2010, exactly… https://t.co/eGPudMExsK
about 19 hours ago
New post on Science and Enterprise: Essay – Ten Years and Counting https://t.co/bIFz5ld4g4 #Science #Business
about 19 hours ago
A cocktail of two synthetic antibodies will soon be tested in a clinical trial to prevent against Covid-19 infectio… https://t.co/auyvJKhyBq
about 21 hours ago

Crispr Heart Therapy Demonstrated in Monkeys

By Alan, on June 29th, 2020%

An experimental therapy using a precise gene editing technique is shown in lab monkeys to reverse the cause of a chronic form of heart disease. . . . → Read More: Crispr Heart Therapy Demonstrated in Monkeys

Single Sensor to Detect Covid-19, Flu in Works

By Alan, on June 26th, 2020%

A university engineering team is developing an electronic sensor to quickly detect and distinguish between Covid-19 and influenza viruses. . . . → Read More: Single Sensor to Detect Covid-19, Flu in Works

Covid-19 Vaccine for Lower-Income Regions Underway

By Alan, on June 8th, 2020%

Researchers in the U.K. designed a vaccine to prevent Covid-19 infections and is starting an enterprise to make it available to lower-income countries. . . . → Read More: Covid-19 Vaccine for Lower-Income Regions Underway

NIH Funds Light-Aided Gene Therapy for Eye Disease

By Alan, on May 29th, 2020%

A company creating a gene therapy for age-related macular degeneration activated with near-infrared rays received an NIH grant to advance its technology. . . . → Read More: NIH Funds Light-Aided Gene Therapy for Eye Disease

Int’l Group Backs Novavax Covid-19 Vaccine

By Alan, on May 12th, 2020%

A global consortium is funding a biotechnology company’s clinical trials and manufacturing plans for a vaccine protecting against Covid-19 viruses. . . . → Read More: Int’l Group Backs Novavax Covid-19 Vaccine

Microscopic Optical Sensor Circuits Demonstrated

By Alan, on April 23rd, 2020%

Researchers exhibited solar-powered integrated circuit sensors with LED lights, smaller than can be seen with the naked eye, for mass production at low cost. . . . → Read More: Microscopic Optical Sensor Circuits Demonstrated

Trial Okayed in Germany for Covid-19 Vaccine

By Alan, on April 23rd, 2020%

Regulators in Germany cleared a clinical trial to begin testing a vaccine with synthetic RNA to prevent coronaviruses from causing Covid-19 infections. . . . → Read More: Trial Okayed in Germany for Covid-19 Vaccine

Fast, Simple Covid-19 Antibody Test Being Developed

By Alan, on April 20th, 2020%

An engineering lab is creating an easy-to-use test of immune-system antibodies to the SARS-Cov-2 virus responsible for Covid-19 infections. . . . → Read More: Fast, Simple Covid-19 Antibody Test Being Developed

Covid-19 Vaccine in Development, Trial Planned

By Alan, on April 8th, 2020%

A biotechnology company specializing in infectious diseases is developing a vaccine to protect against Covid-19 infections, with a clinical trial to start next month. . . . → Read More: Covid-19 Vaccine in Development, Trial Planned

Biotechs Explore Cell Therapy for Covid-19 Antibodies

By Alan, on March 30th, 2020%

Two biotechnology companies are researching use of a non-viral gene therapy to deliver synthetic antibodies for treating Covid-19 infections. . . . → Read More: Biotechs Explore Cell Therapy for Covid-19 Antibodies

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise